The nearly 30-year tale of secalosides A and B began in 1997, when natural product chemists identified them as components of ...
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).